Dietary Phytomix Reduces HbA1c in T2D Patients Through Multiple Mechanisms Including GLP-1 Enhancement | Research

The takeaway

Dibifree dietary phytomix significantly reduced HbA1c and glucose in a 40-patient crossover RCT, working through GLP-1 enhancement, DPP-4 inhibition, AGE reduction, and immune modulation.

Food boosts GLP-1
A dietary supplement enhanced natural GLP-1 secretion while simultaneously inhibiting the enzyme that breaks it down (DPP-4) — mimicking drug effects naturally

What the researchers found

Dibifree: significant HbA1c, FPG, PPG reduction vs placebo in crossover RCT; mechanisms: enhanced GLP-1 secretion, DPP-4/α-glucosidase inhibition, reduced AGE, suppressed adipogenesis, M2 macrophage promotion; transcriptomic reversal of diabetic signatures.

Why it matters

A dietary supplement that works through GLP-1 enhancement and multiple other mechanisms could provide accessible, affordable diabetes management — especially in resource-limited settings.

How the study worked

7-month randomized double-blind placebo-controlled crossover trial (40 T2D patients), with transcriptomic profiling, in vitro/in vivo mechanistic validation including GLP-1 secretion, DPP-4 inhibition, and glucose tolerance in T2D mice.

What this study cannot tell us

Small trial (n=40). Phytomix composition complex — active ingredients not isolated. Cannot determine which component drives which mechanism.

How to read the evidence

Small double-blind crossover RCT with comprehensive mechanistic validation. Stronger than typical supplement studies.

When this study was published

Published in 2025.

The bigger picture

Multi-target dietary interventions that include GLP-1 enhancement could complement pharmaceutical approaches, especially where drug access is limited.

Questions still open

Which specific phytochemicals drive GLP-1 enhancement?
Would Dibifree complement pharmaceutical GLP-1 drugs?
Could this approach reduce GLP-1 drug doses needed?

Common questions

Can diet supplements boost GLP-1 like drugs do?

Dibifree enhanced natural GLP-1 secretion and inhibited the enzyme (DPP-4) that breaks it down — essentially mimicking what GLP-1 drugs do, but through dietary compounds.

Does this replace diabetes medication?

No. It was tested as add-on therapy alongside existing medications. It improved blood sugar control beyond what medications alone achieved, supporting its use as a complement, not replacement.

Read the original research

Dibifree, a dietary phytomix, improves glycemic control and adiposity via modulation of the gut-pancreas-adipose-immune axis in type 2 diabetes.

Food research international (Ottawa, Ont.), 223(Pt 1), 117820

View on PubMed ↗Publisher’s paper ↗

Citation

Huang, Tzu-Yi; Dai, Niann-Tzyy; Liao, Hsiu-Jung; Doan, Ly Hien; Cheng, Tai-Shan; Hsieh, Wen-Yu; Lin, I-Hsuan; Huang, Yu-Tang; Liaw, Chia-Ching; Liu, Hsiao-Sheng; Cheng, Wei-Ming; Su, Chun-Li; Yang, Ching-Wei; Lai, Jin-Mei; Tuan, Mei-Nan; Liu, Hui-Kang; Huang, Chi-Ying F. (2026). Dibifree, a dietary phytomix, improves glycemic control and adiposity via modulation of the gut-pancreas-adipose-immune axis in type 2 diabetes.. Food research international (Ottawa, Ont.), 223(Pt 1), 117820. https://doi.org/10.1016/j.foodres.2025.117820